175 related articles for article (PubMed ID: 7868896)
1. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
Smith RI; Coloma MJ; Morrison SL
J Immunol; 1995 Mar; 154(5):2226-36. PubMed ID: 7868896
[TBL] [Abstract][Full Text] [Related]
2. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
3. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
[TBL] [Abstract][Full Text] [Related]
4. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Tao MH; Morrison SL
J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634
[TBL] [Abstract][Full Text] [Related]
5. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
[TBL] [Abstract][Full Text] [Related]
6. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.
Chintalacharuvu KR; Vuong LU; Loi LA; Larrick JW; Morrison SL
Clin Immunol; 2001 Oct; 101(1):21-31. PubMed ID: 11580223
[TBL] [Abstract][Full Text] [Related]
7. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII.
Goldsmith EB; Erickson BW; Thompson NL
Biochemistry; 1997 Jan; 36(4):952-9. PubMed ID: 9020795
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
10. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.
Zuckier LS; Chang CJ; Scharff MD; Morrison SL
Cancer Res; 1998 Sep; 58(17):3905-8. PubMed ID: 9731501
[TBL] [Abstract][Full Text] [Related]
11. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
[TBL] [Abstract][Full Text] [Related]
12. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
[TBL] [Abstract][Full Text] [Related]
13. Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis.
Arya S; Chen F; Spycher S; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1994 Feb; 152(3):1206-12. PubMed ID: 8301125
[TBL] [Abstract][Full Text] [Related]
14. The hinge as a spacer contributes to covalent assembly and is required for function of IgG.
Coloma MJ; Trinh KR; Wims LA; Morrison SL
J Immunol; 1997 Jan; 158(2):733-40. PubMed ID: 8992989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
16. Studies on antigen binding by intact and hinge-deleted chimeric antibodies.
Horgan C; Brown K; Pincus SH
J Immunol; 1993 Jun; 150(12):5400-7. PubMed ID: 7685795
[TBL] [Abstract][Full Text] [Related]
17. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis.
Brekke OH; Michaelsen TE; Aase A; Sandin RH; Sandlie I
Eur J Immunol; 1994 Oct; 24(10):2542-7. PubMed ID: 7925582
[TBL] [Abstract][Full Text] [Related]
18. Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum.
Luan JJ; Monteiro RC; Sautès C; Fluteau G; Eloy L; Fridman WH; Bach JF; Garchon HJ
J Immunol; 1996 Nov; 157(10):4707-16. PubMed ID: 8906852
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo comparisons of the Fc gamma receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody.
Scallon B; McCarthy S; Radewonuk J; Cai A; Naso M; Raju TS; Capocasale R
Int Immunopharmacol; 2007 Jun; 7(6):761-72. PubMed ID: 17466910
[TBL] [Abstract][Full Text] [Related]
20. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.
Wernersson S; Karlsson MC; Dahlström J; Mattsson R; Verbeek JS; Heyman B
J Immunol; 1999 Jul; 163(2):618-22. PubMed ID: 10395649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
